Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New hepatitis A vaccine affords protection with first dose

June 30, 1999

Sumitomo presents new inhibitors of STAT6 activation

June 29, 1999

Chimeric Therapies initiates pivotal trial evaluating proprietary method for allogeneic BMT

June 25, 1999

Avant achieves milestone in rotavirus vaccine program with SB

June 25, 1999

AM-6898E: new anti-IgE antibody agent for immune disorders

June 24, 1999

PowderJect and Glaxo Wellcome further expand DNA vaccine alliance

June 24, 1999

Vaccines and vaccine vectors comprising auxotrophic attenuated strains of Listeria

June 18, 1999

Potassium channel-modulating immunosuppressants designed at Merck

June 18, 1999

NIAID sponsors phase III trial of varicella vaccine for prevention of shingles

June 18, 1999

Campylobacter vaccine completes phase II trial

June 17, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...